Low Dose Naltrexone for Pain in Patients With HIV
Phase 4
60
about 3.7 years
18–75
3 sites in GA
What this study is about
Researchers are testing whether low dose naltrexone can help reduce pain in people with HIV/AIDS. The trial will monitor CD4 counts as part of routine care to see if the medication improves immune function and reduces symptoms. This could be a new way to manage pain for people living with HIV.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Low Dose Naltrexone
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
NERVOUS SYSTEM
injection (Injection)
Primary: Changes in Numerical Pain Score
Secondary: Changes in Average pain Score, Changes in PROMIS pain Score
Immune, Infectious